Eli Lilly's Mounjaro tops India's drug sales in October, surpassing GSK's Augmentin with ₹100 crore in revenue.

Demand for the blockbuster anti-obesity drugs, which help control blood sugar and slow digestion, has been on an upswing ...

Eli Lilly's weight-loss therapy Mounjaro became India's top-selling drug by value in October, data showed on Friday, ...

Eli Lilly’s blockbuster obesity drug, Mounjaro, became India’s top-selling drug by value in October. Sales hit $11.38 million ...

For Lizzie Day, having Botox was as much a part of her routine as getting her morning coffee. It was only when a doctor ...

Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available ...

The medications seem to dampen the effects of drugs ranging from nicotine to alcohol—but scientists haven’t been able to ...

The Trump administration announced a deal with Eli Lilly and Novo Nordisk to lower the costs of GLP-1 medications, which may ...

TrumpRx.com is currently unavailable minutes after President Donald Trump announced it as a portal for newly discounted weight loss drugs Wegovy and Zepbound.

Medicare cover GLP-1s under a Trump-negotiated pricing plan starting in 2026, lowering costs for key obesity and diabetes drugs.

Trump administration strikes deal with Novo Nordisk and Eli Lilly to slash weight-loss drug costs. Wegovy starting doses drop ...